Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?. (July 2021) - Roviello, Giandomenico; Buti, Sebastiano; Cattrini, Carlo; Mennitto, Alessia; Messina, Carlo; Airoldi, Chiara; Vannini, Gianmarco; Bersanelli, Melissa